A number of large, Danish companies are owned by a foundation. This means that the company's founder irrevocably donates the majority of shares in the company to an independent legal entity, a foundation, with certain rights and responsibilities. No person or legal entity will thereafter own the foundation's assets. The foundation needs to have a non-selfish purpose, and the pharmaceutical sector typically donates money to research and education.
Steno Diabetes Center Copenhagen is one of the early examples of a public-private collaboration. Steno Diabetes Center Copenhagen goes back to the Nordic Insulin Laboratory (now Novo Nordisk), established back in 1923. In 1932, the company established the first Nordic Diabetes Hospital to treat people with diabetes, and the public healthcare system soon realized the potential and entered into a collaboration with the Life Science industry.
The Steno Diabetes Center concept has now been disseminated to the four other regions of Denmark. Steno Diabetes Center Copenhagen is the largest diabetes hospital in Scandinavia, which takes care of approximately 10,000 individuals with diabetes.
The National Genome Center is a recent example of a public-private collaboration with the purpose to support further development of personalized medicine.
The LEO Foundation Skin Immunology Research Center in Copenhagen was established as a collaboration between the University of Copenhagen and the LEO Foundation. It provides a focal point for the best international research in skin, skin diseases and immunology. The center will pave the way for better understanding, prevention and treatment of skin diseases. The LEO Foundation will fund the center with a considerable grant.
Watch video about LEO Foundation Skin Immunology Research Center.